Missed Opportunity for Sotorasib Dose Optimization

Garth W. Strohbehn

Garth W. Strohbehn, MD, MPhil, Rogel Cancer Center, Ann Arbor, MI, VA Center for Clinical Management Research, Ann Arbor, MI; Jill Feldman, MA, EGFR Resisters Patient Advocacy Group, Chicago, IL, Lung Cancer Patient and Advocate, Chicago, IL; Sanjay Popat, MBBS, PhDLung Unit, Royal Marsden Hospital and Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom; and Mark J. Ratain, MD, Section of Hematology/Oncology, University of Chicago, Chicago, IL

Jill Feldman

Patient Advocate EGFR Resisters Deerfield Illinois USA

Sanjay Popat

Mark J. Ratain

Committee on Clinical Pharmacology and Pharmacogenomics and Center for Personalized Therapeutics, The University of Chicago, Chicago, IL